You have 9 free searches left this month | for more free features.

drug-sensitive tuberculosis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

d to Treat Drug Sensitive Tuberculosis in Breastfeeding

Recruiting
  • Tuberculosis Active
  • +2 more
  • First line tuberculosis treatment
  • Kampala, Uganda
    Infectious Diseases Institute
Apr 22, 2023

Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Short Regimen with Rifapentine 10mg/kg
  • +3 more
  • Guiyang, Guizhou, China
  • +5 more
May 28, 2022

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis Trial in Port Au Prince, Bellville (Isoniazid, Vitamin B6)

Completed
  • Tuberculosis
  • Port Au Prince, Haiti
  • +1 more
Mar 16, 2022

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Tuberculosis Trial in Cape Town (GSK3036656, RIFAFOUR e-275)

Completed
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Dec 30, 2021

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary Disease, Tuberculosis, Pulmonary, Tuberculosis Trial in San Antonio (TBAJ-876 10mg, TBAJ-876 25mg, TBAJ-876 50mg)

Active, not recruiting
  • Pulmonary Disease
  • +6 more
  • TBAJ-876 10mg
  • +8 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Sep 2, 2021

Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

Active, not recruiting
  • Infections and Infestations
  • Pulmonary Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +4 more
Sep 13, 2022

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • High-dose rifampicin
  • +4 more
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020

Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

Recruiting
  • Tuberculosis
  • +2 more
  • N acetyl cysteine
  • Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital
Feb 12, 2023

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Tuberculosis Trial in H?i Phòng (Community based TB intervention)

Not yet recruiting
  • Tuberculosis
  • Community based TB intervention
  • Hải Phòng, Vietnam
  • +1 more
Dec 15, 2022

Sensitive Pulmonary Tuberculosis Trial in Beijing, Zhengzhou, Jinan (Pyrifazimine (TBI-166))

Active, not recruiting
  • Sensitive Pulmonary Tuberculosis
  • Pyrifazimine (TBI-166)
  • Beijing, Beijing, China
  • +2 more
Sep 14, 2021

Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

Not yet recruiting
  • Drug-resistant Tuberculosis
  • +2 more
  • Targeted next-generation sequencing
  • Cape Town, South Africa
    South African National Health Laboratory Service
Sep 23, 2022

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

    Not yet recruiting
    • Tuberculosis
    • Human Immunodeficiency Virus
    • Optimised rifamycin
    • (no location specified)
    Oct 8, 2022

    Interferon Gamma Injections in Drug-resistant Pulmonary

    Recruiting
    • Pulmonary Tuberculosis
    • Moscow, Russian Federation
      FSBI "NMIC FPI" of the Ministry of Health of Russia
    May 31, 2022

    Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

    Completed
    • Tuberculosis, MDR
    • Semey, East-Kazakhstan Region, Kazakhstan
    • +5 more
    May 17, 2022

    Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))

    Recruiting
    • Tuberculosis Infection
    • Nivaquine ® (Chloroquine)
    • Zurich, Switzerland
      Clinical Trial Center
    Jun 28, 2022

    Learn More About How Safe Darolutamide is Under Real-world

    Not yet recruiting
    • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
    • No Intervention
    • Multiple Locations, Japan
      Many Locations
    Aug 24, 2023

    Continuous Glucose Monitoring in Diabetic Patients

    Recruiting
    • Tuberculosis
    • Diabetes Mellitus
    • TB Drug Levels
    • London, United Kingdom
      London North West University NHS University Trust
    Apr 7, 2022